-
F-CRIN labélise 4 nouveaux réseaux de recherche clinique
Depuis le 1er janvier 2022 la communauté F-CRIN compte 4 réseaux supplémentaires: ACT4ALS-MND sur la maladie de Charcot et du neurone moteur, F-PSYNET sur les troubles psychotiques, FRADEN sur la Dermatite atopique et STROKELINK sur les accidents vasculaires cérébraux.
F-CRIN in brief
F-CRIN stands for “French Clinical Research Infrastructure Network”. It was set up in 2012 to study human health and diseases. Its main goals are to unlock synergies between French clinical research players by promoting scientific excellence and operational collaboration, and also to represent the European clinical research network – ECRIN-ERIC – in France.
Today, ten years after its founding, F-CRIN operates through an original organisational model of 21 components: 16 theme-based clinical research and investigation networks, 3 networks of advanced expertise, 1 multiservice platform and 1 national coordination unit acting as infrastructure headquarters. F-CRIN now covers over 19 medical fields.
43%
of projects with an international scope
685
research projects involving F-CRIN
51%
of projects conducted with an industrial partners
1,348
publications mentioning F-CRIN or its components
F-CRIN coordination units across France
F-CRIN, a national infrastructure with 21 components across France.
Infrastructure News
No news or press releases
F-CRIN on social networks
FCRIN_network
FCRIN_network
RT @ECRIN_ERIC: SAVE THE DATE: 2 December 2022 is ECRIN CTU Day! This day is dedicated to, and open only to, members of our national partn…
FCRIN_network
FCRIN_network
F-CRIN a labélisé le réseau de #Recherche @FRADEN_FCRIN en 2022. ✅24 centres ✅Conduire des projets translationnels, des essais de validation de concept & améliorer les collaborations pour mieux identifier les profils des patients & personnaliser au mieux leur prise en charge.
FCRIN_network
FCRIN_network
La #DermatiteAtopique, une maladie de la #peau, complexe, chronique et récurrente, pour laquelle les options thérapeutiques sont encore limitées chez l’adulte et l'enfant malgré un impact réel sur la qualité de vie des patients. https://t.co/b5mSDBhfJf https://t.co/9zBFE3J11r
